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Abstract
Background: Clinical application of body composition (BC) measurements for individual children has been limited by lack of
appropriate reference data.
Objectives: (1) To compare fat mass (FM) and fat free mass (FFM) standard deviation scores (SDS) generated using new
body composition reference data and obtained using simple measurement methods in healthy children and patients with
those obtained using the reference 4-component (4-C) model; (2) To determine the extent to which scores from simple
methods agree with those from the 4-C model in identification of abnormal body composition.
Design: FM SDS were calculated for 4-C model, dual-energy X-ray absorptiometry (DXA; GE Lunar Prodigy), BMI and skinfold
thicknesses (SFT); and FFM SDS for 4CM, DXA and bioelectrical impedance analysis (BIA; height2/Z)) in 927 subjects aged
3.8–22.0 y (211 healthy, 716 patients).
Results: DXA was the most accurate method for both FM and FFM SDS in healthy subjects and patients (mean bias (limits of
agreement) FM SDS 0.03 (60.62); FFM SDS 20.04 (60.72)), and provided best agreement with the 4-C model in identifying
abnormal BC (SDS #22 or $2). BMI and SFTs were reasonable predictors of abnormal FM SDS, but poor in providing an
absolute value. BIA was comparable to DXA for FFM SDS and in identifying abnormal subjects.
Conclusions: DXA may be used both for research and clinically to determine FM and FFM SDS. BIA may be used to assess
FFM SDS in place of DXA. BMI and SFTs can be used to measure adiposity for groups but not individuals. The performance
of simpler techniques in monitoring longitudinal BC changes requires investigation. Ultimately, the most appropriate
method should be determined by its predictive value for clinical outcome.
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Introduction
The measurement of body composition, both in clinical practice
and in epidemiological studies, is an area of increasing interest.
However, the use of body composition measurements in children
and adolescents, particularly in a clinical context for individual
patients, has been hampered by the lack of reference data
necessary to standardise measurements for age, gender and size
[1]. We recently addressed this limitation, providing paediatric
reference data using the gold standard 4-component (4-C) model
plus a variety of simpler techniques; these data allow body
composition measurements from individual children to be
expressed as a standard deviation score (SDS) normalised for
age and gender, analogous to the use of weight, height or BMI
SDS [2]. An additional issue preventing the wider use of body
composition measurements in clinical practice is uncertainty about
which method(s) should be used. Whilst the 4-C model is accepted
as the gold standard in vivo, it is not suitable for widespread
clinical use due to the specialised equipment, staff expertise and
time required. A variety of simpler methods can be used to
measure or predict fat mass (FM) and fat free mass (FFM) [3] but it
is not clear to what extent these different techniques are
interchangeable. This is an important issue since it is unlikely
that a single technique will be suitable or available for all patients
under all circumstances.
In this study we measured body composition in healthy children
and patients using a variety of different methods, each of which
provided data for fat mass (FM) and fat free mass (FFM) in SD-
score format. We compared (1) mean technique-specific SD-scores
and (2) the proportions exceeding cut-offs for abnormal body
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composition (defined as SDS ,22 or .+2) for simple techniques
with those from the 4-component model.
Subjects and Methods
Subjects
Body composition data from seven research studies conducted
at the UCL Institute of Child Health were used, including a total
of 927 subjects aged 3.8–22.0 years. Subjects included healthy
children (DX, n= 211), young adults born preterm (PT, n= 191),
obese children (OB, n= 183), and several patient groups (children
with glycogen storage disease (GSD, n= 17), children undergoing
follow-up having been treated for acute lymphoblastic leukaemia
(ALL, n= 24), those with cystic fibrosis (CF, n= 288) and eating
disorders (ED, n= 13)). Data from these subjects were not used to
generate the body composition reference data. Obesity was
defined as a body mass (BMI; in kg/m2) above the 95th percentile
according to UK 1990 reference data [4]. Data points from PT
and ALL groups represent single measurements from cross-
sectional studies; for other groups, longitudinal measurements
from individual subjects have been included (DX 15 with 1 scan,
65 with 2 scans, 22 with 3 scans; OB 15 with 1 scan, 130 with 2
scans, 66 with 3 scans; GSD 2 with 1 scan, 5 with 3 scans; CF 41
with 1 scan, 38 with 2 scans, 27 with 3 scans, 18 with 4 scans, 2
with 5 scans, 1 with 6 scans).
Ethics statement
All studies had received appropriate ethical approval from the
Institute of Child Health and Great Ormond Street Hospital
Research Ethics Committee. In line with this approval, written
informed consent was obtained from the subject if aged 16 years
or above, or from the parent if the subject was less than 16 years of
age. Written assent was obtained from subjects over 10 years of
age and verbal assent from younger subjects. Study data were
anonymised prior to analysis.
Measurements
Weight and height were measured in all subjects during a study
visit, and BMI was calculated as weight/height2. Fat mass (FM)
and fat-free mass (FFM) were measured in all subjects using the 4C
model and one or more ‘simpler’ technique (DXA, BIA and
skinfold thicknesses). Biceps, triceps, subscapular and suprailiac
skinfold thicknesses were measured to the nearest 1 mm using
skinfold callipers. Determination of FM and FFM by DXA used a
Lunar Prodigy whole-body scanner (GE Medical Systems,
Madison, WI) in conjunction with Encore 2002 software. Whole
body impedance at 50 kHz (Z, in V) was measured using a
TANITA BC418MA instrument; the conventional whole-body
impedance index (height2/Z) was calculated and used in
subsequent analyses as an indicator of FFM. Measurements of
FM and FFM from the 4C model were obtained using values of
bone mineral content (BMC), body weight (BW), body volume
(BV) and Total Body Water (TBW), as described in detail
previously [5]. BMC was measured using DXA; BV using the
BodPod (Life Measurement Instruments, Concord, CA), and
TBW using deuterium dilution. From these measurements, the 4C
model derives values for mineral, water, fat and protein as
described previously [5]. FM (kg) = [(2.7476BV) –
(0.7106TBW)] + [(1.4606BMC) – (2.0506BW)]. FFM was taken
as the difference between weight and FM.
All anthropometric data were converted to SD scores (SDS)
using 1990 UK reference data (for weight, height, BMI [4]) or our
new body composition reference data (for FM, FFM, impedance
(HT2/Z) and skinfold thicknesses (SFT) [2]). The reference dataset
comprised an independent sample of 533 children aged 4–
23 years, from whom SDS have been generated for each of the
following body composition outcomes: the 4C model; DXA using
Lunar Prodigy instrumentation; biceps, triceps, subscapular and
supra-iliac skinfolds; HT2/Z using Tanita BC41bMA instrumen-
tation. An excel spreadsheet allows calculation of these SDS using
the LMS ‘growth add-in’ function (LMS Chart Maker; Medical
Research Council, London, United Kingdom) [6]). SDS were
calculated directly from raw skinfold thickness values and
impedance index (height2/Z) values [3] in order to avoid
introducing additional error by using existing published prediction
equations to generate FM and FFM. Body composition SDS
generated using the reference database are analogous to SDS for
weight, height and BMI commonly used to compare a child’s
measurement with the value expected for age and gender in a
healthy child.
Statistical analyses
Data for males and females were pooled within each study
group. Because of the small sample available for certain patient
groups, the study groups were combined to form three ‘disease
groups’; ‘Normal’ (DX and PT; n= 402), ‘Overweight’ (OB, GSD
and ALL; n= 224) and ‘Underweight’ (CF and ED; n= 301). This
grouping was made on the basis of our previous body composition
findings in the different study groups and clinical judgment,
supported by the results of pairwise t-tests between the ‘normal’
DX group and each of the other groups in which the BMI SDS of
the PT group was not significantly different from that of the DX
group, whereas the BMI SDS of the OB, GSD, and ALL groups
was significantly higher whilst that of the CF and ED groups was
significantly lower.
The accuracy of the simpler body composition measurements
was assessed using the ‘gold-standard’ four-component (4C) model
as the reference method for adiposity (4C FM SDS) and FFM (4C
FFM SDS). DXA, SFT and BMI SDS were all used as simple
measurements to generate rankings of adiposity in SDS format;
DXA and BIA (height2/Z) SDS were used as simple measures to
generate rankings of FFM in SDS format. Bland Altman analyses
[7] were used to calculate the bias (the mean difference between
the SDS of the techniques) and the limits of agreement (mean bias
62SD of the difference between techniques). The bias was tested
for significant difference from zero using a one-sample t-test. The
Pearson product-moment correlation coefficient (r) between the
difference and mean SDS was also tested against the null
hypothesis of r = 0 using the one-sample t-test, in order to evaluate
whether the difference in SDS between techniques varied with the
size of the measurement. Analyses were conducted both in the
entire study population and independently in each of the ‘disease
groups’, in order to determine whether this affected agreement
and precision of each technique. Evaluation of SFT as a
measurement of FM was carried out using a limited population
consisting of study groups DX, PT and CF since the remaining
studies did not include SFT measurement as part of their
protocols. Since no subjects were available for the ‘overweight’
group, normal subjects were compared to underweight subjects
only.
We also assessed the ability of each technique to distinguish
‘normal’ and ‘abnormal’ body composition in clinical practice. A
‘normal’ FM or FFM was defined as an SDS between 22 and +2.
This cut-off was chosen as it is frequently used to define normality
in clinical practice. Agreement with the 4C model was evaluated
by cross-tabulation, and by calculation of Cohen’s kappa
coefficient (k) and % agreement. All analyses were performed
Standardised Body Composition Measurements
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using SPSS, version 15.0; SPSS Inc, Chicago, IL. P values ,0.05
were considered significant.
Results
Characteristics of the different subject groups are shown in
Table 1. In the DX and PT study groups, 4C FM SDS did not
differ significantly from zero. However, boys in the DX group and
both sexes in the PT group had significantly low FFM SDS. All
measurements in the OB study group were significantly greater
than zero, and almost all measurements in the CF and ED study
groups were significantly lower.
Accuracy and precision of simpler body composition
measurements against the 4C model
We compared body composition measurements in terms of their
accuracy and precision in predicting 4C FM and FFM SDS.
Results are described below and shown in Figure 1 (results of the
Bland-Altman analysis for DXA, BMI and SFTs as predictors of
4C FM SDS) and Figure 2 (same analyses for DXA and BIA as
predictors of 4C FFM SDS). Figures 3 and 4 summarise the
mean bias and limits of agreement for each measurement method,
both overall and for normal, underweight and overweight groups.
Fat mass. Across the whole study population, when com-
pared to the 4C model, DXA provided the most accurate and
precise measurement of FM SDS, with a mean bias of 0.03
(p = 0.002) and limits of agreement of 60.62. In both the normal
and overweight populations, DXA showed insignificant bias from
4C, with narrow limits of agreement (60.58 and 60.40
respectively), whilst in the underweight group, a stronger positive
bias was observed (0.14, p,0.001) and the limits of agreement
were wider (60.76).
BMI significantly overestimated FM SDS for both the total
population and separate disease groups. The greatest bias was in
the overweight population (mean bias = 0.71), with much lower
biases in the normal and underweight populations (0.26 and 0.38
respectively). In contrast, the limits of agreement for the
overweight population were narrower (60.78) when compared
to those in the normal and underweight groups (61.26 and
61.49).
Bicep SFT SDS measurements showed significant positive bias
across the analyses with wide LOAs in both the normal group
(61.37) and the underweight group (61.40). Tricep SFT also
showed a significant positive bias when compared to the 4C
model. The LOAs were wide, and greater in the underweight
group (61.34) than the normal group (61.09). Subscapular SFT,
like bicep and tricep, significantly overestimated FM, although to a
lesser degree in normal (mean bias = 0.14) than underweight
(mean bias = 0.37) subjects, with wide limits of agreement. Finally,
as was the case for the other SFTs, there was significant positive
bias in the suprailiac SFT, and the limits of agreement were wide.
Comparing different SFTs, tricep SFT demonstrated the greatest
accuracy, showing the smallest positive bias in both the normal
and underweight subject groups and had the lowest LOAs for the
normal group (61.09) and the second lowest for the underweight
group (61.34). Subscapular SFT had the lowest LOAs in this
group (61.34).
Table 1. Characteristics of the study groups1,2.
Group
DX (n=101 M,
110 F)
PT (n =82 M,
109 F)
OB (n=60 M,
123 F)
GSD (n=11 M,
6 F)
ALL (n=11 M,
13 F)
CF (n =129 M,
159 F)
ED (n=0 M,
13 F)
Age (y)
Male 12.661.94 20.360.62 11.562.39 12.765.40 9.561.77 11.762.72 -
Female 12.662.30 20.260.47 11.562.59 16.964.07 9.661.93 11.862.61 15.561.98
Weight SDS
Male 0.161.06 0.061.39 2.960.813 0.661.66 0.760.883 20.261.113 -
Female 0.460.933 0.161.30 3.160.913 0.061.27 0.561.56 20.661.153 21.561.993
Height SDS
Male 0.061.03 20.361.013 1.261.333 20.661.13 0.060.53 20.561.073 -
Female 0.360.793 20.461.113 1.161.143 21.061.34 20.461.06 20.661.163 20.161.29
BMI SDS
Male 0.161.05 0.261.36 3.160.623 1.361.453 0.961.233 0.161.07 -
Female 0.361.073 0.361.293 3.160.693 0.760.83 1.061.403 20.461.103 21.761.043
4C fat mass SDS
Male 0.160.98 20.261.12 2.460.513 0.861.003 0.461.32 20.361.003 -
Female 0.060.93 20.161.01 2.360.583 0.560.53 0.661.14 20.861.153 21.460.933
4C fat-free mass SDS
Male 20.361.043 20.560.893 2.061.643 20.761.50 0.160.82 20.561.093 -
Female 0.160.84 20.661.043 2.161.383 21.261.69 20.461.49 20.961.133 21.261.003
1All values are mean (m) 6 standard deviation (s). DX, control group; PT, preterm birth cohort; OB, obese; GSD, glycogen storage disease; ALL, acute lymphoblastic
leukaemia; CF, cystic fibrosis; ED, eating disorder.
2SDS, SD score relative to the 1990 UK reference data for age, weight, height and BMI; relative to four component (4C) Institute of Child Health (ICH) reference data for
4C fat mass and 4C fat-free mass.
3Significantly different from zero (paired t-test): P,0.05.
doi:10.1371/journal.pone.0062139.t001
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Fat free mass. Measurement of FFM SDS by DXA showed
a small, but significant bias compared to 4C FFM SDS. DXA
underestimated FFM SDS overall (mean bias =20.04) and in the
normal (mean bias =20.06) and underweight (mean bias
=20.09), groups but overestimated it in overweight subjects
(mean bias = 0.07). The limits of agreement were narrow, and
were smallest in the underweight group (60.57) and greatest in the
overweight group (60.92).
In the total study population, when compared to the 4C model,
BIA significantly underestimated FFM SDS (mean bias =20.14,
p,0.001). A negative mean bias was also seen in the overweight
and underweight groups, although the mean bias was positive in
the normal group. BIA was most accurate in normal patients
(mean bias = 0.08) and performed similarly in overweight and
underweight patients (mean bias =20.25, 20.24 respectively).
LOAs for BIA were 61.00 in normal subjects, 60.93in
underweight and 61.15 in overweight patients.
Bland-Altman correlations were used to test whether the mean
bias for each measurement technique was influenced by the mean
FM or FFM SDS (Table 2). For DXA FM there was a significant
negative correlation both before and after adjustment for age and
gender, whilst for BMI SDS there was a positive correlation which
was reduced by these adjustments. For Bicep SFT there was also a
significant negative correlation following adjustment. Tricep SFT
showed significant correlation before adjustment, but adjustment
for age reduced this to an insignificant level. Subscapular and
suprailiac SFT showed insignificant correlations with or without
adjustment. For DXA FFM, there was a significant positive
correlation which was not reduced by adjustment, whilst for BIA
there was no significant correlation.
Assessment of the ability of each technique to
distinguish ‘normal’ and ‘abnormal’ body composition in
clinical practice
Across the total study population, DXA showed higher %
agreement (96%) with 4C FM SDS and higher Cohen’s kappa
value (0.88) than BMI or SFTs, and this was true for all 3 disease
Figure 1. Bland-Altman analyses for the agreement between the 4C model and (A) DXA, (B) BMI, (C) bicep SFT, (D) tricep SFT, (E)
subscapular SFT and (F) suprailiac SFT in the measurement of FM. SD scores (SDS) were calculated using ICH reference data [2]. Difference in
SDS between techniques was calculated by subtracting 4C FM SDS from the FM SDS given by the ‘simpler’ method. Horizontal lines on the graph
indicate the mean difference between techniques, and two standard deviations above and below this value. Different symbols indicate which study
group each subject was from, as shown in the key. 4C model; four-compartment model, DXA; dual-energy X-ray absorptiometry, BMI; body mass
index, SFT; skinfold thickness. DX; healthy children, PT; young adults born preterm, OB; obese children, GSD; glycogen storage disease, ALL; acute
lymphoblastic leukaemia, CF; cystic fibrosis, ED; eating disorders. Evaluation of SFT as a measurement of FM was carried out using a limited
population consisting of study groups DX, PBC and CF. The OB, GSD, ALL and ED studies did not include SFT measurement as part of their protocols.
Since no subjects were available for the overweight disease group, normal subjects were compared to underweight subjects only.
doi:10.1371/journal.pone.0062139.g001
Figure 2. Bland-Altman analyses for the agreement between the 4C model and (A) DXA and (B) BIA in the measurement of FFM. As
for Figure 1, SD scores (SDS) were calculated using ICH reference data [2]. Difference in SDS between techniques was calculated by subtracting 4C
FFM SDS from the FFM SDS given by the ‘simpler’ method. Horizontal lines on the graph indicate the mean difference between techniques, and two
standard deviations above and below this value. Different symbols indicate which study group each subject was from, as shown in the key. 4C model;
four-compartment model, DXA; dual-energy X-ray absorptiometry, BIA; bioelectrical impedance analysis. DX; healthy children, PT; young adults born
preterm, OB; obese children, GSD; glycogen storage disease, ALL; acute lymphoblastic leukaemia, CF; cystic fibrosis, ED; eating disorders.
doi:10.1371/journal.pone.0062139.g002
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groups. Although % agreement suggested lower agreement
between BMI and 4C FM than SFTs, the Cohen’s kappa value
showed BMI to be more accurate (Table 3). Of the SFTs, bicep
was least accurate by far (k=0.13), reflecting the results of the
previous sections. Tricep, subscapular and suprailiac SFT were
comparable (k=0.36, 0.35, 0.35 respectively).
Over the total study population, both % agreement and kappa
values indicated that DXA performed better than BIA in terms of
agreement with 4C FFM (Table 4). DXA showed better
agreement with the 4C model in the overweight and underweight
groups than in the normal group, performing best in the
overweight group (k=0.83). For BIA, the % agreement was
much higher in the normal subject group than in either the
overweight or the underweight group. However, the kappa values
showed that this measurement method is most accurate in the
overweight group (k=0.76), and least accurate in the underweight
group (k=0.56).
Discussion
Body composition is increasingly measured in children and
adolescents both in research studies but also as part of clinical
management. Many methods are available to either predict or
measure FM and FFM and different techniques may be available
or applicable under different conditions [1]. The 4C model
provides the most accurate in vivo measurement of FM and FFM,
and as such is regarded as the ‘gold standard’ of body composition
methods. However, use of the 4C model is both time-consuming
and costly, requiring specialised equipment and operator knowl-
edge. Its use is therefore restricted to research settings. A variety of
‘simpler’ body composition measurement techniques is available
and some are suitable for use in clinical practice. However, it is
unclear which technique is the best, and also the extent to which
different techniques are interchangeable. This is an important
Figure 3. Mean bias and limits of agreement of each ‘simple’ method for measuring fat mass (FM) when compared to the 4C (4
compartment) model: (A) total study population; (B) normal weight group; ((C) overweight group; (D) underweight group.
Difference from 4C FM SDS is calculated by subtracting the 4C FM SDS from that of the simple method. Limits of agreement are calculated as mean
bias 62 standard deviations (SDs). DXA; dual-energy X-ray absorptiometry, BMI; body mass index, SFT; skinfold thickness. Evaluation of SFT as a
measurement of FM was carried out using a limited population consisting of study groups DX, PT and CF. The OB, GSD, ALL and ED studies did not
include SFT measurement as part of their protocols. Since no subjects were available for the overweight disease group, normal subjects were
compared to underweight subjects only.
doi:10.1371/journal.pone.0062139.g003
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Figure 4. Mean bias and limits of agreement of each ‘simple’ method for measuring fat-free mass (FFM) when compared to the 4C
(4 compartment) model: (A) total study population; (B) normal weight group; ((C) overweight group; (D) underweight group.
Difference from 4C FFM SDS is calculated by subtracting the 4C FFM SDS from that of the simple method. Limits of agreement are calculated as mean
bias 62 standard deviations (SDs). DXA; dual-energy X-ray absorptiometry, BIA; bioelectrical impedance analysis.
doi:10.1371/journal.pone.0062139.g004
Table 2. Bland-Altman correlations, unadjusted and adjusted for age, and age and sex1.
Measurement method Unadjusted P Adjusted for Age p
Adjusted for Age
and Sex p
Fat mass
DXA 20.11 0.001 20.15 ,0.001 20.16 ,0.001
BMI 0.34 ,0.001 0.32 ,0.001 0.32 ,0.001
Bicep SFT 20.12 0.001 20.12 0.003 20.110 0.005
Tricep SFT 20.082 0.035 20.0741 0.057 20.0741 0.058
Subscapular SFT 0.0001 0.990 0.0071 0.85 0.0151 0.69
Suprailiac SFT 0.0351 0.38 0.0421 0.28 0.0491 0.22
Fat free mass
DXA 0.14 ,0.001 0.18 ,0.001 0.17 ,0.001
BIA 20.0591 0.14 20.0361 0.37 20.0311 0.44
1Insignificant correlation coefficients (p.0.05).
doi:10.1371/journal.pone.0062139.t002
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issue, as it is unlikely that a single measurement technique will be
either available or suitable for all patients under all circumstances.
Several previous studies have compared DXA measurements of
absolute FM and FFM with those from the 4C model in children
and adults and have suggested relatively poor agreement in terms
of mean bias and LOAs, with factors such as age, gender, pubertal
status, body size and disease group influencing the bias [8–17].
Our recent study [18] also evaluated changes in body composition
in obese individuals using DXA compared to the 4C model and
found a mean bias not significantly different from zero, but wide
limits of agreement for both FM (63.2 kg) and FFM (63.0 kg).
Such findings have led us to emphasise the potential limitations of
DXA for assessing body composition in individual patients or for
longitudinal measurements. Our current study differs from
previous analyses comparing different techniques for measuring
body composition in that we have used values of FM and FFM
that are standardised for age and gender using our new reference
data to provide FM and FFM SDS. These data are more relevant
to the situation in practice where clinicians are evaluating body
composition measurement results for individual children and need
to relate these to expected values for the child’s age and gender.
The lack of reference data has been a major hurdle preventing
the wider use of body composition measurements in clinical
practice for individual patients; although reference datasets have
been generated for specific techniques such as BIA, SFT and DXA
[19–25], none have covered multiple techniques or used the gold
standard 4C model in a single population. Recently, we addressed
this issue, providing reference data for children aged 4–23 years
using the 4C model plus a variety of simpler techniques that for
the first time allow standard deviation scores to be calculated for
different parameters [2]; we plan to make these data available to
researchers and clinicians. The strength of this approach is that it
provides the opportunity to evaluate measurements obtained using
simple body composition measurement techniques which could be
used to provide a measure of FM or FFM in a clinical setting,
against the 4C FM and FFM as the gold standard. DXA, BMI and
SFTs were used to provide FM, and DXA and BIA as indicators of
FFM.
Our evaluation consisted of two parts; first, the comparison of
SDS derived from each technique using Bland-Altman analyses;
and second, the ability of SDS derived from each technique to
categorise subjects as having ‘normal’ or ‘abnormal’ body
composition, which is particularly relevant for clinical practice.
We found DXA SDS to be the most accurate and precise indicator
of both 4C FM SDS and FFM SDS across the entire study
population and in each of the ‘disease groups’ with a mean bias
and limits of agreement of 0.03 and 60.62 for FM and 20.04 and
60.72 for FFM. It also showed good agreement with the 4C
model in the categorisation of subjects into ‘normal’ and
‘abnormal’ body compositions. The use of DXA in clinical
practice as a predictor of standardised 4C FM and FFM and in the
identification of subjects with abnormal body composition is
therefore supported by our findings, although it is important to
note that the limits of agreement for DXA FM and FFM SDS,
whilst the lowest for any method evaluated in this study, are still
fairly wide, indicating that 95% of values obtained from DXA will
fall within a 1.2 or 1.4 SD band of those obtained by the 4C model
for FM and FFM respectively. This suggests that DXA should not
be regarded as interchangeable with the 4C model. DXA is also
less accurate in subjects with low FM. However, regression
analyses indicated that, since all methods evaluated tended to
overestimate 4C FM in the youngest subjects, and DXA
overestimated to the least extent, this is still the optimum method
in this age group. In older subjects, all the methods gave a similar
mean bias, although in different directions, and one possibility in
these subjects would be to use the mean SDS of more than one
method; for example, BMI and DXA, using the ‘wisdom of
crowds’ approach, as we recently discussed [26]. DXA was also the
best choice for both male and female subjects, and the effects of
BMI on the bias were small. The accuracy of DXA might be
Table 3. Cross-tabulation statistics for evaluation of DXA, BMI
and SFTs against 4C FM.
% agreement k 95% CI
Total cohort n=927
DXA 96.0 0.877 0.838–0.916
BMI 86.3 0.644 0.587–0.701
Biceps SFT 90.6 0.126 0.004–0.248
Triceps SFT 92.6 0.361 0.221–0.501
Subscapular SFT 93.2 0.354 0.207–0.501
Suprailiac SFT 93.8 0.347 0.191–0.504
Normal n =402
DXA 97.0 0.714 0.561–0.868
BMI 89.9 0.380 0.224–0.537
Biceps SFT 90.4 0.059 0.000–0.190
Triceps SFT 93.9 0.343 0.142–0.544
Subscapular SFT 94.4 0.329 0.118–0.540
Suprailiac SFT 94.5 0.251 0.033–0.469
Overweight n=224
DXA 95.1 0.900 0.842–0.957
BMI 76.2 0.470 0.342–0.590
Underweight n=301
DXA 95.3 0.699 0.544–0.853
Biceps SFT 90.7 0.215 0.000–0.437
Triceps SFT 90.7 0.370 0.173–0.567
Subscapular SFT 91.5 0.373 0.167–0.579
Suprailiac SFT 92.7 0.425 0.210–0.641
doi:10.1371/journal.pone.0062139.t003
Table 4. Cross-tabulation statistics for evaluation of DXA and
BIA against 4C FFM.
% agreement k 95% CI
Total cohort n=927
DXA 95.2 0.836 0.789–0.889
BIA 91.0 0.731 0.665–0.797
Normal n =402
DXA 97.2 0.690 0.517–0.863
BIA 97.1 0.614 0.339–0.897
Overweight n=224
DXA 91.4 0.831 0.758–0.904
BIA 88.2 0.762 0.667–0.857
Underweight n=301
DXA 95.4 0.805 0.703–0.910
BIA 88.1 0.560 0.419–0.701
doi:10.1371/journal.pone.0062139.t004
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further improved by removing the trunk data and utilising limb
data alone, and this requires further evaluation.
One practical limitation of DXA is that it is perhaps the least
accessible of the methods we considered, so it is important to assess
simpler and more readily available predictors of FM and FFM.
BMI and skinfold thicknesses provided much less agreement with
4C FM than DXA, demonstrating large positive biases and wide
limits of agreement. SFTs provided a slightly more accurate
ranking of 4C FM than BMI, though with similar limits of
agreement in individuals. In addition, BMI and SFTs showed less
agreement with 4C in the categorisation of subjects than DXA.
Based on these results, it would be inadvisable to use either BMI or
SFT SDS as an indicator of FM, even as a crude method to
monitor a child’s progress over time. Indeed, longitudinal
measurement using BMI might be particularly contraindicated,
as the bias observed is affected strongly by changing age and body
composition. Such correlations are less significant for SFTs, and
these might therefore be better for this purpose. Separate analysis
of each of the individual SFTs demonstrated that triceps SFT
demonstrated the highest accuracy in both the normal and
underweight groups, and the smallest LOAs in the normal group
(subscapular SFT had the lowest LOAs in the underweight group).
In circumstances where, for reasons of time or patient compliance,
it may only be possible to take one SFT measurement, our data
suggest that tricep SFT should be the priority, and may be backed
up by subscapular measurement where possible.
In the comparison of DXA and BIA as measurements of FFM
SDS, DXA was the more accurate and precise method. DXA was
also in better agreement with the 4C model for the categorisation
of normal and abnormal body composition. Overall, therefore,
DXA would be the method of choice for predicting 4C FFM.
However, BIA performed reasonably well across the patient
groups included in our study; it produced results close to those
given by DXA, especially in the normal and overweight subjects
groups, and the use of BIA as a predictor of 4C FFM is reasonable
when DXA is unavailable. These are encouraging results, as
technologies for the measurement of BIA are already widely
accessible in primary care centres, although it is important to
appreciate that BIA may perform less well in patient groups who
experience significant abnormalities in hydration. Furthermore,
our reference data were obtained using a single frequency standing
BIA machine, and should be used with caution if measurements
are obtained using other makes and models of machine,
particularly those that require the subject to be measured supine.
When DXA is available, the estimate of 4C FFM could potentially
be strengthened even further by combining the results of DXA and
BIA, following the ‘wisdom of crowds’ principle [26].
We chose to use the impedance index (height2/Z) to generate
FFM SDS rather than converting impedance data to total body
water and then to FFM using published equations, in order to
avoid introducing further error by making assumptions which
would be unlikely to apply across the wide range of age, body size
and disease states present in our subjects. In a recent evaluation,
we reported that height2/Z explained 95% of the variance in 4-C
FFM [27].
There are some limitations to our analyses. Firstly, it is
important to consider whether the fact that DXA provides data
for the 4C body composition SDS as well as being used as a single
measurement may have influenced the results. This issue, which is
shared by all studies comparing DXA with the 4C model, was
addressed in our previous study [8] by repeating Bland-Altman
analyses using the 3-component model, which uses no data from
DXA and is therefore fully independent. The results were
unchanged. Secondly, we did not evaluate the accuracy and
precision of SFT measurements in overweight children, due to a
lack of relevant data. In reality, however, it is often difficult to
obtain accurate SFT measurements from this group so it is unlikely
they would be used clinical practice. Further analyses could also be
performed to compare FM and FFM standardised for height as
FMI (FM/height2) and FFMI (FFM/height2); this is particularly
important for patient groups in whom linear growth may be
abnormal. In our current analyses, we focussed on simple body
composition methods likely to be available in clinical practice.
However, future work should also evaluate other measurements as
predictors of FM and FFM, including waist circumference,
densitometry and isotope dilution. Reference data are available
for these measures, and they may be more appropriate in a
research setting or in epidemiological studies rather than for
individual patient assessment. Finally, we have focussed here on a
cross-sectional comparison between the techniques. However, for
clinical purposes it is also important to investigate how changes in
FM or FFM SDS obtained using the simpler techniques compare
with those from the 4C model. If SD scores from a given technique
perform well in longitudinal modelling, any cross-sectional bias
would be less important.
In conclusion, our study suggests that, of the methods evaluated,
standardised FM and FFM measurements from DXA compare
most favourably with those derived from the 4-C model, and so
should be the most useful in both research and clinical practice.
Because they are reasonable predictors of abnormal FM, BMI and
SFT SDS can be used in identification of subjects for research or
group interventions, but because they are poor for providing an
absolute value, they should not be used in assessing subjects on an
individual basis. BIA may reasonably be used to provide a FFM
SDS in place of DXA. Ultimately, however, the most appropriate
measurement and adjustment for FM or FFM data should be
determined by its predictive value for clinical outcome.
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